Loading…
Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation
The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2010-05, Vol.20 (9), p.2933-2937 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2937 |
container_issue | 9 |
container_start_page | 2933 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 20 |
creator | Ye, Xiang-Yang Chen, Stephanie Zhang, Hao Locke, Kenneth T O'Malley, Kevin Zhang, Litao Srivastava, Raijit Miao, Bowman Meyers, Daniel Monshizadegan, Hossain Search, Debra Grimm, Denise Zhang, Rongan Lippy, Jonathan Twamley, Celeste Muckelbauer, Jodi K Chang, Chiehying An, Yongmi Hosagrahara, Vinayak Zhang, Lisa Yang, T-J Mukherjee, Ranjan Cheng, Peter T W Tino, Joseph A |
description | The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed. |
doi_str_mv | 10.1016/j.bmcl.2010.03.019 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_733897261</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733897261</sourcerecordid><originalsourceid>FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3</originalsourceid><addsrcrecordid>eNp9kctOwzAQRS0kREvhB1gg79jgYsePJMuq4iVVooLuKydxGldOHGKnavrBfAcpLY8Vq9HMHN25ugPAFcFjgom4W4-TMjXjAPcDTMeYxCdgSJhgiDLMB-DcuTXGhGHGzsAgwJSLkIoh-HjrKl8opx2UVQadb9rUt41CMvV6o30HG2Wk17Zyha4dtDkMkGw6gxiyW7mzpjOl8oXddjBR1a4zK9OlulIHvR_WF_p_2MHKbpS5hbX1qvJwPp-8SlMXEjpl1N6Mgl-epLeNQ3_2-zv7biXL8pfeWy9t1h7MX4DTXBqnLo91BBYP94vpE5q9PD5PJzNUcy4Qi-NYYprSMEpiKjJMOM2SgLM8yqkI-6CTWDJMIyICwnPJsigicRjIFMuM84yOwM1Btm7se6ucX5bapcoYWSnbumVIadTzgvTk9ZFsk1Jly7rRZR_V8vsz9BODEZXY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733897261</pqid></control><display><type>article</type><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><source>Elsevier</source><creator>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</creator><creatorcontrib>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</creatorcontrib><description>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</description><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.03.019</identifier><identifier>PMID: 20356736</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Anti-Inflammatory Agents - chemical synthesis ; Anti-Inflammatory Agents - chemistry ; Anti-Inflammatory Agents - pharmacokinetics ; Binding Sites ; Cricetinae ; Crystallography, X-Ray ; Glycine - analogs & derivatives ; Glycine - chemical synthesis ; Glycine - pharmacokinetics ; Humans ; Male ; PPAR alpha - agonists ; PPAR alpha - metabolism ; PPAR gamma - agonists ; PPAR gamma - metabolism ; Rats ; Rats, Sprague-Dawley ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2933-2937</ispartof><rights>2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20356736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ye, Xiang-Yang</creatorcontrib><creatorcontrib>Chen, Stephanie</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Locke, Kenneth T</creatorcontrib><creatorcontrib>O'Malley, Kevin</creatorcontrib><creatorcontrib>Zhang, Litao</creatorcontrib><creatorcontrib>Srivastava, Raijit</creatorcontrib><creatorcontrib>Miao, Bowman</creatorcontrib><creatorcontrib>Meyers, Daniel</creatorcontrib><creatorcontrib>Monshizadegan, Hossain</creatorcontrib><creatorcontrib>Search, Debra</creatorcontrib><creatorcontrib>Grimm, Denise</creatorcontrib><creatorcontrib>Zhang, Rongan</creatorcontrib><creatorcontrib>Lippy, Jonathan</creatorcontrib><creatorcontrib>Twamley, Celeste</creatorcontrib><creatorcontrib>Muckelbauer, Jodi K</creatorcontrib><creatorcontrib>Chang, Chiehying</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Hosagrahara, Vinayak</creatorcontrib><creatorcontrib>Zhang, Lisa</creatorcontrib><creatorcontrib>Yang, T-J</creatorcontrib><creatorcontrib>Mukherjee, Ranjan</creatorcontrib><creatorcontrib>Cheng, Peter T W</creatorcontrib><creatorcontrib>Tino, Joseph A</creatorcontrib><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - chemical synthesis</subject><subject>Anti-Inflammatory Agents - chemistry</subject><subject>Anti-Inflammatory Agents - pharmacokinetics</subject><subject>Binding Sites</subject><subject>Cricetinae</subject><subject>Crystallography, X-Ray</subject><subject>Glycine - analogs & derivatives</subject><subject>Glycine - chemical synthesis</subject><subject>Glycine - pharmacokinetics</subject><subject>Humans</subject><subject>Male</subject><subject>PPAR alpha - agonists</subject><subject>PPAR alpha - metabolism</subject><subject>PPAR gamma - agonists</subject><subject>PPAR gamma - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Structure-Activity Relationship</subject><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kctOwzAQRS0kREvhB1gg79jgYsePJMuq4iVVooLuKydxGldOHGKnavrBfAcpLY8Vq9HMHN25ugPAFcFjgom4W4-TMjXjAPcDTMeYxCdgSJhgiDLMB-DcuTXGhGHGzsAgwJSLkIoh-HjrKl8opx2UVQadb9rUt41CMvV6o30HG2Wk17Zyha4dtDkMkGw6gxiyW7mzpjOl8oXddjBR1a4zK9OlulIHvR_WF_p_2MHKbpS5hbX1qvJwPp-8SlMXEjpl1N6Mgl-epLeNQ3_2-zv7biXL8pfeWy9t1h7MX4DTXBqnLo91BBYP94vpE5q9PD5PJzNUcy4Qi-NYYprSMEpiKjJMOM2SgLM8yqkI-6CTWDJMIyICwnPJsigicRjIFMuM84yOwM1Btm7se6ucX5bapcoYWSnbumVIadTzgvTk9ZFsk1Jly7rRZR_V8vsz9BODEZXY</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Ye, Xiang-Yang</creator><creator>Chen, Stephanie</creator><creator>Zhang, Hao</creator><creator>Locke, Kenneth T</creator><creator>O'Malley, Kevin</creator><creator>Zhang, Litao</creator><creator>Srivastava, Raijit</creator><creator>Miao, Bowman</creator><creator>Meyers, Daniel</creator><creator>Monshizadegan, Hossain</creator><creator>Search, Debra</creator><creator>Grimm, Denise</creator><creator>Zhang, Rongan</creator><creator>Lippy, Jonathan</creator><creator>Twamley, Celeste</creator><creator>Muckelbauer, Jodi K</creator><creator>Chang, Chiehying</creator><creator>An, Yongmi</creator><creator>Hosagrahara, Vinayak</creator><creator>Zhang, Lisa</creator><creator>Yang, T-J</creator><creator>Mukherjee, Ranjan</creator><creator>Cheng, Peter T W</creator><creator>Tino, Joseph A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</title><author>Ye, Xiang-Yang ; Chen, Stephanie ; Zhang, Hao ; Locke, Kenneth T ; O'Malley, Kevin ; Zhang, Litao ; Srivastava, Raijit ; Miao, Bowman ; Meyers, Daniel ; Monshizadegan, Hossain ; Search, Debra ; Grimm, Denise ; Zhang, Rongan ; Lippy, Jonathan ; Twamley, Celeste ; Muckelbauer, Jodi K ; Chang, Chiehying ; An, Yongmi ; Hosagrahara, Vinayak ; Zhang, Lisa ; Yang, T-J ; Mukherjee, Ranjan ; Cheng, Peter T W ; Tino, Joseph A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - chemical synthesis</topic><topic>Anti-Inflammatory Agents - chemistry</topic><topic>Anti-Inflammatory Agents - pharmacokinetics</topic><topic>Binding Sites</topic><topic>Cricetinae</topic><topic>Crystallography, X-Ray</topic><topic>Glycine - analogs & derivatives</topic><topic>Glycine - chemical synthesis</topic><topic>Glycine - pharmacokinetics</topic><topic>Humans</topic><topic>Male</topic><topic>PPAR alpha - agonists</topic><topic>PPAR alpha - metabolism</topic><topic>PPAR gamma - agonists</topic><topic>PPAR gamma - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ye, Xiang-Yang</creatorcontrib><creatorcontrib>Chen, Stephanie</creatorcontrib><creatorcontrib>Zhang, Hao</creatorcontrib><creatorcontrib>Locke, Kenneth T</creatorcontrib><creatorcontrib>O'Malley, Kevin</creatorcontrib><creatorcontrib>Zhang, Litao</creatorcontrib><creatorcontrib>Srivastava, Raijit</creatorcontrib><creatorcontrib>Miao, Bowman</creatorcontrib><creatorcontrib>Meyers, Daniel</creatorcontrib><creatorcontrib>Monshizadegan, Hossain</creatorcontrib><creatorcontrib>Search, Debra</creatorcontrib><creatorcontrib>Grimm, Denise</creatorcontrib><creatorcontrib>Zhang, Rongan</creatorcontrib><creatorcontrib>Lippy, Jonathan</creatorcontrib><creatorcontrib>Twamley, Celeste</creatorcontrib><creatorcontrib>Muckelbauer, Jodi K</creatorcontrib><creatorcontrib>Chang, Chiehying</creatorcontrib><creatorcontrib>An, Yongmi</creatorcontrib><creatorcontrib>Hosagrahara, Vinayak</creatorcontrib><creatorcontrib>Zhang, Lisa</creatorcontrib><creatorcontrib>Yang, T-J</creatorcontrib><creatorcontrib>Mukherjee, Ranjan</creatorcontrib><creatorcontrib>Cheng, Peter T W</creatorcontrib><creatorcontrib>Tino, Joseph A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ye, Xiang-Yang</au><au>Chen, Stephanie</au><au>Zhang, Hao</au><au>Locke, Kenneth T</au><au>O'Malley, Kevin</au><au>Zhang, Litao</au><au>Srivastava, Raijit</au><au>Miao, Bowman</au><au>Meyers, Daniel</au><au>Monshizadegan, Hossain</au><au>Search, Debra</au><au>Grimm, Denise</au><au>Zhang, Rongan</au><au>Lippy, Jonathan</au><au>Twamley, Celeste</au><au>Muckelbauer, Jodi K</au><au>Chang, Chiehying</au><au>An, Yongmi</au><au>Hosagrahara, Vinayak</au><au>Zhang, Lisa</au><au>Yang, T-J</au><au>Mukherjee, Ranjan</au><au>Cheng, Peter T W</au><au>Tino, Joseph A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>20</volume><issue>9</issue><spage>2933</spage><epage>2937</epage><pages>2933-2937</pages><eissn>1464-3405</eissn><abstract>The synthesis and follow-up SAR studies of our development candidate 1 by incorporating 2-aryl-4-oxazolylmethoxy and 2-aryl-4-thiazolylmethoxy moieties into the oxybenzylglycine framework of the PPARalpha/gamma dual agonist muraglitazar is described. SAR studies indicate that different substituents on the aryloxazole/thiazole moieties as well as the choice of carbamate substituent on the glycine moiety can significantly modulate the selectivity of PPARalpha versus PPARgamma. Potent, highly selective PPARalpha activators 2a and 2l, as well as PPARalpha activators with significant PPARgamma activity, such as 2s, were identified. The in vivo pharmacology of these compounds in preclinical animal models as well as their ADME profiles are discussed.</abstract><cop>England</cop><pmid>20356736</pmid><doi>10.1016/j.bmcl.2010.03.019</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1464-3405 |
ispartof | Bioorganic & medicinal chemistry letters, 2010-05, Vol.20 (9), p.2933-2937 |
issn | 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_733897261 |
source | Elsevier |
subjects | Animals Anti-Inflammatory Agents - chemical synthesis Anti-Inflammatory Agents - chemistry Anti-Inflammatory Agents - pharmacokinetics Binding Sites Cricetinae Crystallography, X-Ray Glycine - analogs & derivatives Glycine - chemical synthesis Glycine - pharmacokinetics Humans Male PPAR alpha - agonists PPAR alpha - metabolism PPAR gamma - agonists PPAR gamma - metabolism Rats Rats, Sprague-Dawley Structure-Activity Relationship |
title | Synthesis and structure-activity relationships of 2-aryl-4-oxazolylmethoxy benzylglycines and 2-aryl-4-thiazolylmethoxy benzylglycines as novel, potent PPARalpha selective activators- PPARalpha and PPARgamma selectivity modulation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A33%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20structure-activity%20relationships%20of%202-aryl-4-oxazolylmethoxy%20benzylglycines%20and%202-aryl-4-thiazolylmethoxy%20benzylglycines%20as%20novel,%20potent%20PPARalpha%20selective%20activators-%20PPARalpha%20and%20PPARgamma%20selectivity%20modulation&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Ye,%20Xiang-Yang&rft.date=2010-05-01&rft.volume=20&rft.issue=9&rft.spage=2933&rft.epage=2937&rft.pages=2933-2937&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.03.019&rft_dat=%3Cproquest_pubme%3E733897261%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p556-4999a03c378b936d0153db254f8f367101b9a403816215fa4d881972ac0ad55d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733897261&rft_id=info:pmid/20356736&rfr_iscdi=true |